Cohort study to evaluate efficacy, safety and acceptability of a two-rod contraceptive implant during third, fourth and fifth year of product use in China

[1]  D. Taylor,et al.  Randomized trial to evaluate contraceptive efficacy, safety and acceptability of a two-rod contraceptive implant over 4 years in the Dominican Republic , 2019, Contraception: X.

[2]  R. Jacobstein.  Liftoff: The Blossoming of Contraceptive Implant Use in Africa , 2018, Global Health: Science and Practice.

[3]  Moazzam Ali,et al.  Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant , 2016, Human reproduction.

[4]  P. Feldblum,et al.  Implant removal experience with Sino-implant (II) at four Chinese sites. , 2014, Contraception.

[5]  J. Trussell,et al.  Sino-implant (II)--a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials. , 2010, Contraception.

[6]  Christina Wang,et al.  Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men. , 2006, The Journal of clinical endocrinology and metabolism.

[7]  D. Mishell,et al.  Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants. , 2001, Contraception.

[8]  I. Sivin,et al.  The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study. , 1998, Human reproduction.

[9]  D. Mishell,et al.  Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic. , 1998, Contraception.

[10]  A. Faúndes,et al.  Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants. , 1998, Contraception.

[11]  A. Faúndes,et al.  Free levonorgestrel index and its relationship with luteal activity during long-term use of Norplant implants , 1992, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[12]  V. Odlind,et al.  “Free Levonorgestrel Index” (FLI) is a better parameter than plasma level of levonorgestrel for predicting risk of pregnancy during use of subdermal contraceptive implants releasing levonorgestrel , 1988, Steroids.

[13]  L. Kovács,et al.  A multicentred pharmacokinetic. pharmacodynamic study of once-a-month injectable contraceptives I. Different doses of HRP112 and of depoprovera , 1987 .